MAFLD:探索肝脏以外的系统性影响
Utkarsh Dayal1, Ujjwal Soni2, Sourav Bansal3
1Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA.
Journal of community hospital internal medicine perspectives
|January 27, 2025
概括
与代谢功能障碍相关的脂肪肝疾病 (MAFLD) 与慢性病和心血管疾病的风险增加有关. 了解肠-肝-轴是管理这些相互关联的健康问题的关键.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
背景情况:
- 与代谢功能障碍相关的脂肪肝疾病 (MAFLD) 是一种由肥胖和糖尿病驱动的普遍疾病.
- MAFLD涵盖了一系列的肝脏脂肪积累,从简单的肥胖症到晚期肝脏疾病.
- MAFLD与重大并发症有关,包括慢性病 (CKD) 和心血管疾病 (CVD).
研究的目的:
- 审查MAFLD,心血管并发症和脏问题之间的复杂联系.
- 突出肠-肝-轴在MAFLD病变发生过程中的作用.
- 强调了解病理生理路径对于管理MAFLD相关风险的重要性.
主要方法:
- 对当前科学文献进行前性审查.
- 对代谢功能障碍,肝病,肠道微生物组和全身并发症之间的相互作用研究的分析.
- 综合证据,将炎症,氧化应激和胰岛素抵抗与MAFLD并发症联系起来.
主要成果:
- MAFLD的发病包括炎症,氧化应激,胰岛素抵抗和内皮功能障碍,有助于心血管疾病风险.
- 肠道功能障碍越来越被认为是MAFLD的一个因素,特别是与CKD的关联.
- 肝硬化和代谢功能障碍是MAFLD诊断及其与其他肝脏疾病的同时发生的核心因素.
结论:
- MAFLD显著增加了CKD,CVD和其他肝脏并发症的风险.
- 肠-肝-轴在MAFLD及其相关疾病的发展和进展中发挥着关键作用.
- 对这些相互关联的途径进行进一步的研究对于有效的临床管理和预防策略至关重要.
相关概念视频
Toxic Reactions: Overview
934
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
934
Inflammatory Bowel Disease I: Ulcerative Colitis
131
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
131
Diseases of the Liver and Gallbladder
419
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
419
Liver Physiology
413
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
413


